Overview

A Study to Test Whether ZS (Sodium Zirconium Cyclosilicate) Can Reduce the Incidence of Increased Blood Potassium Levels Among Dialized Patients.

Status:
Completed

Trial end date:
2018-11-07

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy of ZS in the treatment of hyperkalemia in patients on hemodialysis.

Phase:

Phase 3

Details

Lead Sponsor:

AstraZeneca